These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 2537414
1. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats. Docherty JR. J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414 [Abstract] [Full Text] [Related]
2. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat. Docherty JR, Warnock P. J Cardiovasc Pharmacol; 1987 Feb; 10 Suppl 3():S59-61. PubMed ID: 2446073 [Abstract] [Full Text] [Related]
3. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat. Dabiré H, Chaouche-Teyara K, Cherqui C, Fournier B, Schmitt H. Arch Int Pharmacodyn Ther; 1990 Feb; 306():57-64. PubMed ID: 1981667 [Abstract] [Full Text] [Related]
4. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat. Deckert V, Chaouloff F, Richer C, Elghozi JL. Arch Int Pharmacodyn Ther; 1990 Feb; 306():114-29. PubMed ID: 1981665 [Abstract] [Full Text] [Related]
6. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Centurión D, Mehotra S, Sánchez-López A, Gupta S, MaassenVanDenBrink A, Villalón CM. Eur J Pharmacol; 2006 Mar 27; 535(1-3):234-42. PubMed ID: 16545797 [Abstract] [Full Text] [Related]
7. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors? Ramage AG. J Cardiovasc Pharmacol; 1988 Mar 27; 11 Suppl 1():S30-4. PubMed ID: 2459511 [Abstract] [Full Text] [Related]
8. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B, Gradin K, Pettersson A, Hedner T. J Cardiovasc Pharmacol; 1988 Mar 27; 11 Suppl 1():S22-4. PubMed ID: 2459509 [Abstract] [Full Text] [Related]
9. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation. Dabiré H. Therapie; 1991 Mar 27; 46(6):421-9. PubMed ID: 1819150 [Abstract] [Full Text] [Related]
10. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. Cohen ML, Fuller RW, Kurz KD. J Pharmacol Exp Ther; 1983 Nov 27; 227(2):327-32. PubMed ID: 6313898 [Abstract] [Full Text] [Related]
11. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats. Balasubramaniam G, Lee HS, Mah SC. J Pharmacol Exp Ther; 1993 Jan 27; 264(1):129-34. PubMed ID: 8093720 [Abstract] [Full Text] [Related]
12. Differences in vasodilating action between ketanserin, a 5-HT2-serotonergic receptor antagonist, and terazosin, an alpha 1-adrenoceptor antagonist, in anesthetized rabbits. Ikeda K, Takata M, Tomoda F, Mikawa M, Iida H, Sasayama S. J Cardiovasc Pharmacol; 1987 Jan 27; 10 Suppl 3():S69-72. PubMed ID: 2446076 [Abstract] [Full Text] [Related]
13. Differences in the chronic hypotensive mechanism of action of ketanserin in spontaneously hypertensive and Wistar-Kyoto rats. Balasubramaniam G, Lee HS, Mah SC. J Hypertens; 1994 Jan 27; 12(1):7-14. PubMed ID: 8157947 [Abstract] [Full Text] [Related]
14. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors. Shen FM, Wang J, Ni CR, Yu JG, Wang WZ, Su DF. Clin Exp Pharmacol Physiol; 2007 Aug 27; 34(8):702-7. PubMed ID: 17600544 [Abstract] [Full Text] [Related]
16. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. Chaouloff F, Jeanrenaud B. J Pharmacol Exp Ther; 1987 Dec 27; 243(3):1159-66. PubMed ID: 2826757 [Abstract] [Full Text] [Related]
17. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil. Mandal AK, Kellar KJ, Friedman E, Pineo SV, Hamosh P, Gillis RA. J Pharmacol Exp Ther; 1989 Nov 27; 251(2):563-70. PubMed ID: 2530339 [Abstract] [Full Text] [Related]
18. Serotonin agonists and antagonists in experimental hypertension. Saxena PR, Bolt GR, Dhasmana KM. J Cardiovasc Pharmacol; 1987 Nov 27; 10 Suppl 3():S12-8. PubMed ID: 2446059 [Abstract] [Full Text] [Related]
19. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR. Scalbert E, Richer C, Giudicelli JF. J Cardiovasc Pharmacol; 1989 Jan 27; 13(1):94-104. PubMed ID: 2468942 [Abstract] [Full Text] [Related]
20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF. J Pharmacol Exp Ther; 1984 Mar 27; 228(3):779-91. PubMed ID: 6707926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]